Chatfield-Reed, K., Gui, S., O’Neill, W. Q., Teknos, T. N., & Pan, Q. (2019). HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Oral Oncol.
Citação norma ChicagoChatfield-Reed, Kate, Shanying Gui, Wendi Q. O’Neill, Theodoros N. Teknos, and Quintin Pan. "HPV33+ HNSCC Is Associated With Poor Prognosis and Has Unique Genomic and Immunologic Landscapes." Oral Oncol 2019.
Citação norma MLAChatfield-Reed, Kate, et al. "HPV33+ HNSCC Is Associated With Poor Prognosis and Has Unique Genomic and Immunologic Landscapes." Oral Oncol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.